Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
1.490
+0.150 (11.19%)
At close: Nov 11, 2026, 4:00 PM EST
1.500
+0.010 (0.67%)
After-hours: Nov 11, 2026, 4:27 PM EST
Purple Biotech Market Cap
Purple Biotech has a market cap or net worth of $10.49 million as of November 11, 2026. Its market cap has increased by 74.01% in one year.
Market Cap
10.49M
Enterprise Value
4.68M
1-Year Change
74.01%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since July 14, 2013, Purple Biotech's market cap has increased from $4.97M to $10.49M, an increase of 110.94%. That is a compound annual growth rate of 5.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 10.49M | 49.88% |
| Dec 31, 2025 | 7.00M | -36.83% |
| Dec 31, 2024 | 11.07M | -48.88% |
| Dec 31, 2023 | 21.67M | -19.15% |
| Dec 29, 2022 | 26.80M | -60.87% |
| Dec 30, 2021 | 68.47M | 2.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Psyence Biomedical | 11.65M |
| Palatin Technologies | 11.18M |
| Vyome Holdings | 10.88M |
| MetaVia | 10.74M |
| Intensity Therapeutics | 10.58M |
| Radiopharm Theranostics | 10.55M |
| CalciMedica | 10.31M |
| Lisata Therapeutics | 10.27M |